Ted Buchan & Co Has $240,000 Holdings in Zoetis Inc. (NYSE:ZTS)

Ted Buchan & Co decreased its holdings in Zoetis Inc. (NYSE:ZTS) by 7.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,230 shares of the company’s stock after selling 100 shares during the period. Ted Buchan & Co’s holdings in Zoetis were worth $240,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Prevail Innovative Wealth Advisors LLC grew its stake in Zoetis by 24.5% in the first quarter. Prevail Innovative Wealth Advisors LLC now owns 18,977 shares of the company’s stock valued at $3,211,000 after purchasing an additional 3,738 shares in the last quarter. M&G Plc acquired a new stake in shares of Zoetis during the 1st quarter valued at about $19,819,000. Cetera Investment Advisers grew its stake in shares of Zoetis by 275.2% in the 1st quarter. Cetera Investment Advisers now owns 96,085 shares of the company’s stock valued at $16,259,000 after buying an additional 70,476 shares in the last quarter. Sei Investments Co. increased its holdings in Zoetis by 19.6% in the first quarter. Sei Investments Co. now owns 370,069 shares of the company’s stock worth $62,622,000 after buying an additional 60,698 shares during the last quarter. Finally, Acadian Asset Management LLC raised its position in Zoetis by 49.6% during the first quarter. Acadian Asset Management LLC now owns 25,051 shares of the company’s stock valued at $4,235,000 after acquiring an additional 8,302 shares in the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have commented on ZTS shares. Stifel Nicolaus boosted their target price on shares of Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a research report on Wednesday, September 18th. BTIG Research upped their price objective on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, August 12th. JPMorgan Chase & Co. raised their target price on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Argus raised Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Finally, Piper Sandler increased their price objective on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, August 14th. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Zoetis has a consensus rating of “Buy” and an average target price of $221.44.

Zoetis Price Performance

NYSE ZTS opened at $176.82 on Friday. The stock has a 50-day simple moving average of $188.15 and a 200 day simple moving average of $179.35. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $201.92. The stock has a market capitalization of $79.78 billion, a PE ratio of 33.24, a P/E/G ratio of 2.71 and a beta of 0.90. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.09 and a current ratio of 3.69.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. The company had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The company’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.36 earnings per share. Research analysts anticipate that Zoetis Inc. will post 5.9 EPS for the current year.

Zoetis Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be given a $0.432 dividend. The ex-dividend date of this dividend is Thursday, October 31st. This represents a $1.73 annualized dividend and a yield of 0.98%. Zoetis’s dividend payout ratio is 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.